Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
Clover Health Investments has delivered a very large 3 year return, yet the stock still screens as undervalued on the broader checks, which raises the question of how much of the story current buyers are actually pricing in.
-
Clover Health Investments has returned about 3.8x over 3 years, which puts recent pullbacks into context as part of a much larger move.
-
Progress around its AI enabled Counterpart Assistant can support expectations for stronger operating performance, while any setback in execution or managed care conditions may weigh on how durable those expectations look.
-
The stock scores highly on valuation checks, with 5 out of 6 suggesting the shares lean cheap compared to key fundamentals.
The issue now is whether Clover Health Investments’ recent gains already reflect this stronger setup, or if the current valuation still leaves room for more upside before the story looks fully priced in.
Is Clover Health Investments Still Cheap on Sales?
The P/S ratio is a useful lens for Clover Health Investments because revenue is a clearer reference point than earnings for a business where profitability metrics can move around. On this measure, Clover Health Investments trades at about 1.1x trailing sales, below the Healthcare sector average of roughly 1.5x and below the peer group level of about 2.3x.
The valuation model in this article suggests a fair P/S ratio of about 1.3x given Clover Health Investments’ profile, which is still above the current multiple. Despite recent analyst upgrades that have increased interest in the stock, the shares are not trading at the same sales multiple that similar businesses currently trade at, or at the level that the model indicates could be reasonable for the company.
On the preferred P/S metric, Clover Health Investments stock appears undervalued relative to both its indicated fair multiple in this model and sector peers.
See what the numbers say about this price — find out in our valuation breakdown.
The Clover Health Investments Narrative: What Would Justify Today’s Price?
For Clover Health Investments, Simply Wall St Narratives pick up where the valuation checks leave off by detailing the specific paths for revenue, margins and earnings that would need to occur for the stock to be worth materially more or less than where it trades today on the market. Instead of stopping at a single valuation figure, they outline the future that figure depends on, so you can monitor how reality aligns with the story on the Community page.
